Domov › Rak mehurja › Missouri › St. Louis
Klinične študije za Rak mehurja v St. Louis, MO
22 študij za Rak mehurja išče udeležence na lokacijah v St. Louis in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.
Uradno besedilo študije (angleško)
Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
Vključevanje udeležencevFaza 1
- Washington University School of Medicine in St. Louis, St Louis
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci
- Mercy Infusion Center - Chippewa, St Louis
- Mercy Hospital South, St Louis
- Missouri Baptist Medical Center, St Louis
- in še 4
Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial
Vključevanje udeležencevFaza 2
- Mercy Hospital South, St Louis
- Missouri Baptist Medical Center, St Louis
- Mercy Hospital Saint Louis, St Louis
- in še 1
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Vključevanje udeležencevFaza 2
- Washington University, School of Medicine, St Louis
Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial
Vključevanje udeležencevFaza 2
- Cancer Care Center of O'Fallon, O'Fallon · 16 mi stran
- HSHS Saint Elizabeth's Hospital, O'Fallon · 16 mi stran
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
Vključevanje udeležencevFaza 2
- Washington University School of Medicine, St Louis
- Mercy Hospital South, St Louis
- Siteman Cancer Center-South County, St Louis
- in še 5
Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
Vključevanje udeležencevFaza 1/2
- Siteman Cancer Center, St Louis
- Barnes-Jewish Hospital, St Louis
- Washington University School of Medicine - Siteman Cancer Center, St Louis
- in še 5
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Vključevanje udeležencevFaza 3
- Washington University School of Medicine, St Louis
Personalized Cancer Vaccine (PCV) Strategy in Patients With Solid Tumors and Molecular Residual Disease
Vključevanje udeležencevFaza 1
- Washington University School of Medicine, St Louis
Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
Vključevanje udeležencevFaza 1/2
- Washington University, St Louis
Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
Vključevanje udeležencevFaza 2
- Specialty Clinical Research of St. Louis, St Louis
Ovarian-Sparing Adaptive Radiotherapy in Young Adult Women
Vključevanje udeležencevOpazovalna študija
- Washington University School of Medicine, St Louis
The Vanguard Study: Testing a New Way to Screen for Cancer
Vključevanje udeležencevVabljeni zdravi prostovoljci
- Washington University School of Medicine, St Louis
Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer
Vključevanje udeležencevFaza 2
- Renown Regional Medical Center, St Louis
- Specialty Clinic Research of St. Louis, St Louis
Efficacy and Safety of Intravesical TARA-002 Compared With Investigator's Choice of Intravesical Chemotherapy in Participants With BCG-naïve High-grade Non-muscle Invasive Bladder Cancer
Vključevanje udeležencevFaza 3
- Renown Regional Medical Center, St Louis
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
Vključevanje udeležencevFaza 1
- Washington University in St. Louis, St Louis
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study
Vključevanje udeležencevFaza 3
- Mercy Hospital South, St Louis
- Missouri Baptist Medical Center, St Louis
- Mercy Hospital Saint Louis, St Louis
- in še 4
IDOV-Immune for Advanced Solid Tumors
Vključevanje udeležencevFaza 1
- Washington University School of Medicine, St Louis
Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies (ELEPHAS-05)
Vključevanje udeležencevOpazovalna študija
- Mercy Hospital - South, St Louis
- Mercy Hospital -STL, St Louis
Clinical Evaluation of BCDx for Monitoring of Recurrence in Non-Muscle Invasive Bladder Cancer
Vključevanje udeležencevOpazovalna študija
- Washington University, St Louis
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
Vključevanje udeležencevFaza 1/2
- Washington University, St Louis
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Vključevanje udeležencevOpazovalna študija
- Massive Bio SYNERGY-AI site, St Louis
Študije za Rak mehurja v drugih mestih
- New York City, NY35 študij
- Nashville, TN31 študij
- Houston, TX31 študij
- Dallas, TX27 študij
- Boston, MA26 študij
- Washington, DC26 študij
- Los Angeles, CA24 študij
- Baltimore, MD24 študij
- Philadelphia, PA21 študij
- Seattle, WA21 študij
- Edison, NJ21 študij
- Chicago, IL21 študij
Druge študije v St. Louis
- Nemalicelični pljučni rak73 študij
- Rak dojke64 študij
- Metastatski rak54 študij
- Kolorektalni rak50 študij
- Rak prostate46 študij
- Rak (vse vrste)46 študij
- Rak pljuč39 študij
- Rak jajčnikov38 študij
- Rak trebušne slinavke33 študij
- Rak endometrija29 študij
- Ploščatocelični karcinom glave in vratu28 študij
- Srčno popuščanje26 študij
Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.